IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 115 filers reported holding IMMUNOVANT INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,082,477 | +76.1% | 1,252,474 | -13.0% | 12.15% | +46.6% |
| Q2 2023 | $27,308,150 | +22.3% | 1,439,544 | 0.0% | 8.29% | -4.4% |
| Q1 2023 | $22,327,327 | +83758.5% | 1,439,544 | -4.0% | 8.67% | -2.0% |
| Q4 2022 | $26,625 | -99.9% | 1,500,000 | -65.5% | 8.85% | +55.9% |
| Q3 2022 | $24,262,000 | +39.9% | 4,348,017 | -2.2% | 5.68% | +29.3% |
| Q2 2022 | $17,347,000 | -59.2% | 4,448,017 | -42.4% | 4.39% | -17.0% |
| Q1 2022 | $42,556,000 | +66.1% | 7,723,578 | +156.9% | 5.29% | +40.4% |
| Q4 2021 | $25,620,000 | -1.7% | 3,007,000 | +0.2% | 3.77% | -36.4% |
| Q3 2021 | $26,072,000 | +23.3% | 3,000,200 | +50.0% | 5.92% | +105.6% |
| Q2 2021 | $21,140,000 | +20.1% | 2,000,000 | +82.3% | 2.88% | +70.7% |
| Q1 2021 | $17,596,000 | – | 1,096,978 | – | 1.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 4,448,017 | $17,347,000 | 4.39% |
| Deep Track Capital, LP | 9,455,000 | $36,875,000 | 2.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233 | $60,000,000 | 0.63% |
| Octagon Capital Advisors LP | 579,061 | $2,258,000 | 0.60% |
| Eventide Asset Management | 5,372,512 | $20,953,000 | 0.45% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 174,000 | $679,000 | 0.29% |
| Frazier Life Sciences Management, L.P. | 585,759 | $2,284,000 | 0.22% |
| BCK CAPITAL MANAGEMENT LP | 54,293 | $212,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 777,590 | $3,033,000 | 0.12% |
| Bridgefront Capital, LLC | 15,649 | $61,000 | 0.07% |